Does general anaesthesia with xenon gas improve protection of the brain when compared to general anaesthesia with a standard anaesthetic agent?

Phase 4

Completed

• Conditions: eurotoxicity; Lithotripsy; General anaesthesia; Neurotoxicity; Neurological - Other neurological disorders; Anaesthesiology - Anaesthetics

• Registration Number: ACTRN12618000916246
• Lead Sponsor: St. Vincent's Hospital Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-31
• Study Completion: 2019-10-31
• Last Update Posted: 14 September 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Patients' undergoing lithotripsy at St. Vincent's Hospital, Melbourne.
Patients' living within 30minutes travel time of St. Vincent's Hospital.

Exclusion Criteria

Exclusion criteria include:
High risk of PONV (Apfel score 3 or greater)
Severe respiratory disease (unable to tolerate inspired oxygen fraction less than 35%)
Contraindication to airway management with laryngeal mask airway
Contraindication to anaesthesia with a volatile agent
Pre-existing neurodegenerative condition

Study & Design

• Study Type: Interventional
• Study Design: Not specified